Triclosan

Triclosan

SCHEMBL526378

Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl.Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

fabI

The experimentally established mechanism targets of Triclosan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 6/20 1.00
HPGD P15428 2/20 1.00
NR1I2 O75469 1/20 1.00
LMNA P02545 1/20 1.00
PGR P06401 1/20 1.00
HSP90AA1 P07900 1/20 1.00
ADORA3 P0DMS8 1/20 1.00
MAPT P10636 1/20 1.00
HSPA5 P11021 1/20 1.00
CBR1 P16152 1/20 1.00
TBXA2R P21731 1/20 1.00
SLC6A2 P23975 1/20 1.00
AGTR1 P30556 1/20 1.00
SLC6A3 Q01959 1/20 1.00
TSHR P16473 2/20 0.52
HSD17B10 Q99714 2/20 0.52
ALDH1A1 P00352 2/20 0.52
CYP3A4 P08684 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triclosan SCHEMBL3269 1.00 TTR (1.00) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL29354475 1.00 TTR (1.00) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL29356111 1.00 TTR (1.00) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL29367506 1.00 TTR (1.00) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL8015104 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL8975439 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL1146628 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL3895700 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL8055151 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL434693 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 836 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112760318-A Reagent composition for stabilizing nucleic acid molecules and application thereof 苏州白垩纪生物科技有限公司 2021-05-07 CN claimed
US-20130059320-A1 Selective growth media for campylobacter bacteria and plating media with said growth media RESTAINO LAWRENCE (US) 2013-03-07 US claimed
WO-2012018888-A2 AN ANTISEPTIC LIQUID FORMULATION, A METHOD FOR ITS USE, AND A METHOD FOR PREPARING THE FORMULATION DERMA-GLOVE LLC (US) 2012-02-09 WO claimed
US-20120034314-A1 Antiseptic Liquid Formulation, A Method for Its Use, and A Method for Preparing the Formulation DERMA-GLOVE LLC 2012-02-09 US claimed
EP-0966248-B2 COMPOSITIONS FOR TREATING KERATINOUS MATERIALS CONTAINING A COMBINATION OF A ZWITTERION POLYMER AND A WATER INSOLUBLE NON-VOLATILE SILICON OREAL (FR) 2008-04-02 EP claimed
EP-1486199-B1 Alcoholic aerosol deodorant composition containing zinc salicylate OREAL (FR) 2007-10-17 EP claimed
US-6759051-B2 HALOGENATED ALKYLNYL CARBAMATE AND A SATURATED OR UNSATURATED ACYLIC, CYCLIC POLYOL OR POLYOL ETHER FOR THE TREATMENT OF INFLAMMATORY AND/OR DESQUAMATING SKIN DISORDERS ASSOCIATED WITH MALASSEZIA SPECIES; ANTIDANDRUFF AGENT L'OREAL (FR) 2004-07-06 US claimed
US-20010019722-A1 Anti-acne chrono patch THALLIUM HOLDING COMPANY, LLC 2001-09-06 US claimed
US-6280764-B1 PATCH FOR THERAPY OF ACNE LAVIPHARM LABORATORIES INC. 2001-08-28 US claimed
US-5976565-A Device for topical treatment of acne and its method of manufacture LAVIPHARM LABORATORIES, INC. (US) 1999-11-02 US claimed
EP-0836469-A4 BACTERICIDAL COMPOSITION PROCTER & GAMBLE (US) 1999-09-15 EP claimed
EP-0836469-A1 BACTERICIDAL COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1998-04-22 EP claimed
WO-1997002010-A1 BACTERICIDAL COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-01-23 WO claimed
EP-0201134-A2 Deodorant formulation with modulating effect on perspiration EURAND ITALIA S.p.A. (IT) 1986-11-12 EP claimed
US-3992729-A Carrier or support means for disposable bedpans MILLS KENNETH WILSON 1976-11-23 US claimed
EP-4736840-A2 LACTOBACILLUS PLANTARUM FOR SKIN CARE Symrise AG (DE) 2026-05-06 EP disclosed
EP-4025675-B1 A PERFUME OIL MIXTURE SYMRISE AG (DE) 2026-03-18 EP disclosed
US-4012512-A GROWTH-PROMOTING AGENTS CIBA-GEIGY CORPORATION (US) 1977-03-15 US disclosed
US-3992729-A Carrier or support means for disposable bedpans MILLS KENNETH WILSON 1976-11-23 US disclosed
US-3940430-A AMINOALKYL SCHWARZ SERVICES INTERNATIONAL LTD. (US) 1976-02-24 US disclosed